Home Parenteral Nutrition in Patients with Advanced Cancer: A Systematic Review and Meta-Analysis

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30. doi:10.3322/caac.21442
   PubMed Web of Science ®Google Scholar
• Kim SH, Shin DW, Kim SY, Yang HK, Nam E, Jho HJ, Ahn E, Cho BL, Park K, Park J-H. Terminal versus advanced cancer: do the general population and health care professionals share a common language? Cancer Res Treat. 2016;48(2):759–767. doi:10.4143/crt.2015.124
   PubMed Web of Science ®Google Scholar
• Ryan AM, Power DG, Daly L, Cushen SJ, Ní Bhuachalla Ē, Prado CM. Cancer-associated malnutrition, cachexia and sarcopenia: the skeleton in the hospital closet 40 years later. Proc Nutr Soc. 2016;75(2):199–211. doi:10.1017/S002966511500419X
   PubMed Web of Science ®Google Scholar
• Baracos VE, Martin L, Korc M, Guttridge DC, Fearon KCH. Cancer-associated cachexia. Nat Rev Dis Primers. 2018;4:17105. doi:10.1038/nrdp.2017.105
   PubMed Web of Science ®Google Scholar
• Sadeghi M, Keshavarz-Fathi M, Baracos V, Arends J, Mahmoudi M, Rezaei N. Cancer cachexia: diagnosis, assessment, and treatment. Crit Rev Oncol Hematol. 2018;127:91–104. doi:10.1016/j.critrevonc.2018.05.006
   PubMed Web of Science ®Google Scholar
• Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12(5):489–495. doi:10.1016/S1470-2045(10)70218-7
   PubMed Web of Science ®Google Scholar
• Hopkinson JB, Wright DN, McDonald JW, Corner JL. The prevalence of concern about weight loss and change in eating habits in people with advanced cancer. J Pain Symptom Manage. 2006;32(4):322–331. doi:10.1016/j.jpainsymman.2006.05.012
   PubMed Web of Science ®Google Scholar
• Pironi L, Arends J, Baxter J, Bozzetti F, Peláez RB, Cuerda C, Forbes A, Gabe S, Gillanders L, Holst M, et al. ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults. Clin Nutr. 2015;34(2):171–180. doi:10.1016/j.clnu.2014.08.017
   PubMed Web of Science ®Google Scholar
• Pironi L, Arends J, Bozzetti F, Cuerda C, Gillanders L, Jeppesen PB, Joly F, Kelly D, Lal S, Staun M, et al. ESPEN guidelines on chronic intestinal failure in adults. Clin Nutr. 2016;35(2):247–307. doi:10.1016/j.clnu.2016.01.020
   PubMed Web of Science ®Google Scholar
• Prado CMM, Baracos VE, McCargar LJ, Reiman T, Mourtzakis M, Tonkin K, Mackey JR, Koski S, Pituskin E, Sawyer MB. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res. 2009;15(8):2920–2926. doi:10.1158/1078-0432.CCR-08-2242
   PubMed Web of Science ®Google Scholar
• Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, Fearon K, Hütterer E, Isenring E, Kaasa S, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017;36(1):11–48. doi:10.1016/j.clnu.2016.07.015
   PubMed Web of Science ®Google Scholar
• Staun M, Pironi L, Bozzetti F, Baxter J, Forbes A, Joly F, Jeppesen P, Moreno J, Hébuterne X, Pertkiewicz M, ESPEN, et al. ESPEN guidelines on parenteral nutrition: home parenteral nutrition (HPN) in adult patients. Clin Nutr. 2009;28(4):467–479. doi:10.1016/j.clnu.2009.04.001
   PubMed Web of Science ®Google Scholar
• Bakker H, Bozzetti F, Staun M, Leon-Sanz M, Hebuterne X, Pertkiewicz M, Shaffer J, Thul P. Home parenteral nutrition in adults: a european multicentre survey in 1997. ESPEN-Home Artificial Nutrition Working Group. Clin Nutr. 1999;18(3):135–140. doi:10.1054/clnu.1999.0021
   PubMed Web of Science ®Google Scholar
• British Artificial Nutrition Survey (BANS). BANS report 2016: artificial nutrition support in the UK 2005-2015, adult home parenteral nutrition & home intravenous fluids. Worcestershire: BAPEN (British Association of Parenteral and Enteral Nutrition); 2016.
   Google Scholar
• Keane N, Fragkos KC, Patel PS, Bertsch F, Mehta SJ, Di Caro S, Rahman F. Performance status, prognostic scoring, and parenteral nutrition requirements predict survival in patients with advanced cancer receiving home parenteral nutrition. Nutr Cancer. 2018;70(1):73–82. doi:10.1080/01635581.2018.1380206
   PubMed Web of Science ®Google Scholar
• Arhip L, García-Peris P, Romero RM, Frías L, Bretón I, Camblor M, Motilla M, Velasco C, Morales A, Carrascal ML, et al. Direct costs of a home parenteral nutrition programme. Clin Nutr. 2019;38(4):1945–1951. doi:10.1016/j.clnu.2018.06.972
   PubMed Web of Science ®Google Scholar
• Bozzetti F, Mori V. Nutritional support and tumour growth in humans: a narrative review of the literature. Clin Nutr. 2009;28(3):226–230. doi:10.1016/j.clnu.2009.02.006
   PubMed Web of Science ®Google Scholar
• Deshayes E, de Forges H, Fraisse J, Eberlé MC, Guillemard S, Fallières A, Pouget JP, Tétreau R, Kotzki PO, Santoro L, et al. Artificial nutrition in patients with cancer has no impact on tumour glucose metabolism: results of the PETANC Study. Clin Nutr. 2019;38(5):2121–2126. doi:10.1016/j.clnu.2018.08.033
   PubMed Web of Science ®Google Scholar
• Sowerbutts AM, Lal S, Sremanakova J, Clamp A, Todd C, Jayson GC, Teubner A, Raftery A-M, Sutton EJ, Hardy L, et al. Home parenteral nutrition for people with inoperable malignant bowel obstruction. Cochrane Database Syst Rev. 2018;8:CD012812. doi:10.1002/14651858.CD012812.pub2
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG, Group P, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–269, W64. doi:10.7326/0003-4819-151-4-200908180-00135
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Green S, Cochrane Collaboration. Cochrane handbook for systematic reviews of interventions. Chichester: Wiley-Blackwell; 2008.
   Google Scholar
• Viswanathan M, Berkman ND. Development of the RTI item bank on risk of bias and precision of observational studies. J Clin Epidemiol. 2012;65(2):163–178. doi:10.1016/j.jclinepi.2011.05.008
   PubMed Web of Science ®Google Scholar
• Douglas E, McMillan DC. Towards a simple objective framework for the investigation and treatment of cancer cachexia: the Glasgow Prognostic Score. Cancer Treat Rev. 2014;40(6):685–691. doi:10.1016/j.ctrv.2013.11.007
   PubMed Web of Science ®Google Scholar
• Kelly CM, Shahrokni A. Moving beyond Karnofsky and ECOG performance status assessments with new technologies. J Oncol. 2016;2016:6186543. doi:10.1155/2016/6186543
   PubMed Web of Science ®Google Scholar
• Peus D, Newcomb N, Hofer S. Appraisal of the Karnofsky performance status and proposal of a simple algorithmic system for its evaluation. BMC Med Inform Decis Mak. 2013;13:72. doi:10.1186/1472-6947-13-72
   PubMed Web of Science ®Google Scholar
• Fayers P, Bottomley A, Group EQoL. Quality of life U: quality of life research within the EORTC-the EORTC QLQ-C30. European Organisation for Research and Treatment of Cancer. Eur J Cancer. 2002;38(Suppl 4):125–133. doi:10.1016/S0959-8049(01)00448-8
   PubMed Web of Science ®Google Scholar
• de Haes JC, van Knippenberg FC, Neijt JP. Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Cancer. 1990;62(6):1034–1038. doi:10.1038/bjc.1990.434
   PubMed Web of Science ®Google Scholar
• Fairclough DL, Cella DF. Functional assessment of cancer therapy (FACT-G): non-response to individual questions. Qual Life Res. 1996;5(3):321–329. doi:10.1007/BF00433916
   PubMed Web of Science ®Google Scholar
• Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5(1):13. doi:10.1186/1471-2288-5-13
   PubMedGoogle Scholar
• Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135. doi:10.1186/1471-2288-14-135
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560. doi:10.1136/bmj.327.7414.557
   PubMed Web of Science ®Google Scholar
• Bowden J, Tierney JF, Copas AJ, Burdett S. Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics. BMC Med Res Methodol. 2011;11:41. doi:10.1186/1471-2288-11-41
   PubMed Web of Science ®Google Scholar
• Fragkos KC, Tsagris M, Frangos CC. Publication bias in meta-analysis: confidence intervals for Rosenthal's fail-safe number. Int Sch Res Notices. 2014;2014:825383. doi:10.1155/2014/825383
   PubMedGoogle Scholar
• Huedo-Medina TB, Sanchez-Meca J, Marin-Martinez F, Botella J. Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods. 2006;11(2):193–206. doi:10.1037/1082-989X.11.2.193
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–1558. doi:10.1002/sim.1186
   PubMed Web of Science ®Google Scholar
• Lundholm K, Daneryd P, Bosaeus I, Korner U, Lindholm E. Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease: effects on survival, metabolism, and function. Cancer. 2004;100(9):1967–1977. doi:10.1002/cncr.20160
   PubMed Web of Science ®Google Scholar
• Ruggeri E, Agostini F, Fettucciari L, Giannantonio M, Pironi L, Pannuti F. Home artificial nutrition in advanced cancer patients. Tumori. 2013;99(2):218–224. doi:10.1700/1283.14195
   PubMed Web of Science ®Google Scholar
• Theilla M, Cohen J, Kagan I, Attal-Singer J, Lev S, Singer P. Home parenteral nutrition for advanced cancer patients: contributes to survival? Nutrition. 2018;54:197–200. doi:10.1016/j.nut.2017.03.005
   PubMed Web of Science ®Google Scholar
• Pasanisi F, Orban A, Scalfi L, Alfonsi L, Santarpia L, Zurlo E, Celona A, Potenza A, Contaldo F. Predictors of survival in terminal-cancer patients with irreversible bowel obstruction receiving home parenteral nutrition. Nutrition. 2001;17(7-8):581–584. doi:10.1016/S0899-9007(01)00579-2
   PubMed Web of Science ®Google Scholar
• Bozzetti F, Cozzaglio L, Biganzoli E, Chiavenna G, De Cicco M, Donati D, Gilli G, Percolla S, Pironi L. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clin Nutr. 2002;21(4):281–288. doi:10.1054/clnu.2002.0560
   PubMed Web of Science ®Google Scholar
• Duerksen DR, Ting E, Thomson P, McCurdy K, Linscer J, Larsen-Celhar S, Brennenstuhl E. Is there a role for TPN in terminally ill patients with bowel obstruction? Nutrition. 2004;20(9):760–763. doi:10.1016/j.nut.2004.05.010
   PubMed Web of Science ®Google Scholar
• Hoda D, Jatoi A, Burnes J, Loprinzi C, Kelly D. Should patients with advanced, incurable cancers ever be sent home with total parenteral nutrition? A single institution's 20-year experience Cancer. 2005;103(4):863–868. doi:10.1002/cncr.20824
   PubMed Web of Science ®Google Scholar
• Santarpia L, Alfonsi L, Pasanisi F, De Caprio C, Scalfi L, Contaldo F. Predictive factors of survival in patients with peritoneal carcinomatosis on home parenteral nutrition. Nutrition. 2006;22(4):355–360. doi:10.1016/j.nut.2005.06.011
   PubMed Web of Science ®Google Scholar
• Fan BG. Parenteral nutrition prolongs the survival of patients associated with malignant gastrointestinal obstruction. JPEN J Parenter Enteral Nutr. 2007;31(6):508–510. doi:10.1177/0148607107031006508
   PubMed Web of Science ®Google Scholar
• Wang M-Y, Wu M-H, Hsieh D-Y, Lin L-J, Lee P-H, Chen W-J, Lin M-T. Home parenteral nutrition support in adults: experience of a medical center in Asia. JPEN J Parenter Enteral Nutr. 2007;31(4):306–310. doi:10.1177/0148607107031004306
   PubMed Web of Science ®Google Scholar
• Soo I, Gramlich L. Use of parenteral nutrition in patients with advanced cancer. Appl Physiol Nutr Metab. 2008;33(1):102–106. doi:10.1139/H07-152
   PubMed Web of Science ®Google Scholar
• Pelzer U, Arnold D, Gövercin M, Stieler J, Doerken B, Riess H, Oettle H. Parenteral nutrition support for patients with pancreatic cancer. Results of a phase II study. BMC Cancer. 2010;10:86. doi:10.1186/1471-2407-10-86
   PubMed Web of Science ®Google Scholar
• Madhok BM, Yeluri S, Haigh K, Burton A, Broadhead T, Jayne DG. Parenteral nutrition for patients with advanced ovarian malignancy. J Hum Nutr Diet. 2011;24(2):187–191. doi:10.1111/j.1365-277X.2010.01127.x
   PubMed Web of Science ®Google Scholar
• Chermesh I, Mashiach T, Amit A, Haim N, Papier I, Efergan R, Lachter J, Eliakim R. Home parenteral nutrition (HTPN) for incurable patients with cancer with gastrointestinal obstruction: do the benefits outweigh the risks? Med Oncol. 2011;28(1):83–88. doi:10.1007/s12032-010-9426-2
   PubMed Web of Science ®Google Scholar
• Bozzetti F, Santarpia L, Pironi L, Thul P, Klek S, Gavazzi C, Tinivella M, Joly F, Jonkers C, Baxter J, et al. The prognosis of incurable cachectic cancer patients on home parenteral nutrition: a multi-centre observational study with prospective follow-up of 414 patients. Ann Oncol. 2014;25(2):487–493. doi:10.1093/annonc/mdt549
   PubMed Web of Science ®Google Scholar
• Vashi PG, Dahlk S, Popiel B, Lammersfeld CA, Ireton-Jones C, Gupta D. A longitudinal study investigating quality of life and nutritional outcomes in advanced cancer patients receiving home parenteral nutrition. BMC Cancer. 2014;14(1):593. doi:10.1186/1471-2407-14-593
   PubMed Web of Science ®Google Scholar
• Drissi M, Cwieluch O, Lechner P, Radziwill R, Vehling-Kaiser U, Hengst K, Masin M. Nutrition care in patients with cancer: a retrospective multicenter analysis of current practice - Indications for further studies? Clin Nutr. 2015;34(2):207–211. doi:10.1016/j.clnu.2014.03.002
   PubMed Web of Science ®Google Scholar
• Senesse P, Tadmouri A, Culine S, Dufour PR, Seys P, Radji A, Rotarski M, Balian A, Chambrier C. A prospective observational study assessing home parenteral nutrition in patients with gastrointestinal cancer: benefits for quality of life. J Pain Symptom Manage. 2015;49(2):183–191.e2. doi:10.1016/j.jpainsymman.2014.05.016
   PubMed Web of Science ®Google Scholar
• Cotogni P, De Carli L, Passera R, Amerio ML, Agnello E, Fadda M, Ossola M, Monge T, De Francesco A, Bozzetti F, et al. Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Med. 2017;6(7):1799–1806. doi:10.1002/cam4.1111
   PubMed Web of Science ®Google Scholar
• Vashi PG, Virginkar N, Popiel B, Edwin P, Gupta D. Incidence of and factors associated with catheter-related bloodstream infection in patients with advanced solid tumors on home parenteral nutrition managed using a standardized catheter care protocol. BMC Infect Dis. 2017;17(1):372. doi:10.1186/s12879-017-2469-7
   PubMed Web of Science ®Google Scholar
• Cotogni P, Monge T, Fadda M, De Francesco A. Bioelectrical impedance analysis for monitoring cancer patients receiving chemotherapy and home parenteral nutrition. BMC Cancer. 2018;18(1):990. doi:10.1186/s12885-018-4904-6
   PubMed Web of Science ®Google Scholar
• Bozzetti F, Arends J, Lundholm K, Micklewright A, Zurcher G, Muscaritoli M. ESPEN guidelines on parenteral nutrition: non-surgical oncology. Clin Nutr. 2009;28(4):445–454. doi:10.1016/j.clnu.2009.04.011
   PubMed Web of Science ®Google Scholar
• Arnold F. Clinical care of hunger strikers. Lancet. 2008;372(9649):1544. doi:10.1016/S0140-6736(08)61650-5
   PubMed Web of Science ®Google Scholar
• August DA, Thorn D, Fisher RL, Welchek CM. Home parenteral nutrition for patients with inoperable malignant bowel obstruction. JPEN J Parenter Enteral Nutr. 1991;15(3):323–327. doi:10.1177/0148607191015003323
   PubMed Web of Science ®Google Scholar
• UN General Assembly. Universal declaration of human rights. UN General Assembly. 1948;302(2).
   Google Scholar
• Silvestri G, Pritchard R, Welch HG. Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews. BMJ. 1998;317(7161):771–775. doi:10.1136/bmj.317.7161.771
   PubMed Web of Science ®Google Scholar